Cargando…

Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine

Global burden of cervical cancer, the most common cause of mortality caused by human papillomavirus (HPV), is expected to increase during the next decade, mainly because current alternatives for HPV vaccination and cervical cancer screening programs are costly to be established in low-and-middle inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xueer, Yang, Fan, Mariz, Filipe, Osen, Wolfram, Bolchi, Angelo, Ottonello, Simone, Müller, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498061/ https://www.ncbi.nlm.nih.gov/pubmed/32886721 http://dx.doi.org/10.1371/journal.ppat.1008827

Ejemplares similares

A broadly protective vaccine against cutaneous human papillomaviruses
por: Mariz, Filipe Colaco, et al.
Publicado: (2022)

Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles
por: Yang, Fan, et al.
Publicado: (2020)

Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
por: Cavazzini, Davide, et al.
Publicado: (2022)

A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope
por: Canali, Elena, et al.
Publicado: (2014)

Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles
por: Spagnoli, Gloria, et al.
Publicado: (2017)

Moonlighting transcriptional activation function of a fungal sulfur metabolism enzyme
por: Levati, Elisabetta, et al.
Publicado: (2016)

Human papillomavirus16 E6 but not E7 upregulates GLUT1 expression in lung cancer cells by upregulating thioredoxin expression
por: Gao, Zi-Yu, et al.
Publicado: (2021)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

A Long Way: History of the Prophylactic Papillomavirus Vaccine
por: Müller, Martin, et al.
Publicado: (2007)

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
por: Mariz, Filipe Colaco, et al.
Publicado: (2023)

Author Correction: A family of archaea-like carboxylesterases preferentially expressed in the symbiotic phase of the mycorrhizal fungus Tuber melanosporum
por: Cavazzini, Davide, et al.
Publicado: (2018)

A family of archaea-like carboxylesterases preferentially expressed in the symbiotic phase of the mycorrhizal fungus Tuber melanosporum
por: Cavazzini, Davide, et al.
Publicado: (2017)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm
por: Boni, Carolina, et al.
Publicado: (2021)

Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin
por: Nakajima, Atsushi, et al.
Publicado: (2012)

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
por: Kordaß, Theresa, et al.
Publicado: (2018)

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
por: Ahmels, Melinda, et al.
Publicado: (2022)

Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
por: Akhatova, Ayazhan, et al.
Publicado: (2022)

Human papillomavirus E6 and E7: What remains?
por: Vats, Arushi, et al.
Publicado: (2021)

Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins
por: Minoni, Lucia, et al.
Publicado: (2020)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
por: Kuroda, M, et al.
Publicado: (2005)

Thioredoxin Reductase Activity Predicts Gold Nanoparticle Radiosensitization Effect
por: Penninckx, Sébastien, et al.
Publicado: (2019)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
por: Qayyum, Naila, et al.
Publicado: (2021)

The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein
por: Hwang, Jungwon, et al.
Publicado: (2014)

Thioredoxin Profiling of Multiple Thioredoxin-Like Proteins in Staphylococcus aureus
por: Peng, Hui, et al.
Publicado: (2018)

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein
por: Laurson, Joanna, et al.
Publicado: (2010)

Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
por: Reily-Bell, Ashley L., et al.
Publicado: (2020)

Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent
por: de Oliveira, Jonatas Rafael, et al.
Publicado: (2019)

Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase
por: Srivastava, Milan, et al.
Publicado: (2011)

Prophylactic and therapeutic vaccines for obesity
por: Na, Ha-Na, et al.
Publicado: (2014)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review
por: Akhatova, Ayazhan, et al.
Publicado: (2021)

The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia
por: Amhaz, Sadek, et al.
Publicado: (2023)

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
por: Phua, Kyle K. L., et al.
Publicado: (2014)

Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation
por: Karlenius, Therese Christina, et al.
Publicado: (2010)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
por: Pal, Asmita, et al.
Publicado: (2020)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

Oncogenic comparison of human papillomavirus type 58 E7 variants
por: Law, Priscilla TY, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ks8i5pm2g5vbppf9f1dok7ik6b